These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35739516)

  • 1. Prevention and control of non-communicable diseases in iran: the case for Investment.
    Yousefi M; Dastan I; Alinezhad F; Ranjbar M; Hamelmann C; Ostovar A; Moghisi A; Mohammadi S; Mataria A; Hammerich A; Slama S; Pourghazian N; Hezaveh AM; Valizadeh B; Torabi P; Najmi M; Moradi M; Hodjatzadeh A; Keshvari-Shad F
    BMC Public Health; 2022 Jun; 22(1):1248. PubMed ID: 35739516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation.
    Elmusharaf K; Grafton D; Jung JS; Roberts E; Al-Farsi Y; Al Nooh AA; Bin Belaila B; ElShamy A; Al-Zuabi H; Al Mutawa KA; Alraisi S; Al Lawat N; Gharbal A; Alomary S; Kulikov A; Pourghazian N; Slama S; Tarlton D; Banatvala N
    BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35649631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
    Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
    Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
    Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
    PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an organizational capacity assessment tool and capacity-building package for the National Center for Prevention and Control of Noncommunicable Diseases in Iran.
    Bakhtiari A; Takian A; Ostovar A; Behzadifar M; Mohamadi E; Ramezani M
    PLoS One; 2023; 18(6):e0287743. PubMed ID: 37384743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting research priorities to achieve long-term health targets in Iran.
    Mansoori P; Majdzadeh R; Abdi Z; Rudan I; Chan KY; ; Aarabi M; Ahmadnezhad E; Ahmadnia S; Akhondzadeh S; Azin A; Azizi F; Dehnavieh R; Eini-Zinab H; Farzadfar F; Farzaei MH; Ghanei M; Haghdoost A; Hantoushzadeh S; Heydari G; Joulaei H; Kalantari N; Kelishadi R; Khosravi A; Larijani B; Mahvi AH; Bavani ARM; Mesdaghinia A; Mokri A; Montazeri A; Mostafavi E; Motevalian SA; Naddafi K; Nikfar S; Nojoumi SA; Noroozian M; Olyaeemanesh A; Omidvar N; Ostadtaghizadeh A; Pourmalek F; Rahimi R; Rahimi-Movaghar A; Rashidian A; Razaghi E; Sadeghi-Bazargani H; Zalani GS; Soori H; Tabrizi JS; Vedadhir A; Yazdizadeh B; Yunesian M; Zare M
    J Glob Health; 2018 Dec; 8(2):020702. PubMed ID: 30356511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
    Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
    Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis.
    Santos AC; Willumsen J; Meheus F; Ilbawi A; Bull FC
    Lancet Glob Health; 2023 Jan; 11(1):e32-e39. PubMed ID: 36480931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective.
    Kasaie P; Weir B; Schnure M; Dun C; Pennington J; Teng Y; Wamai R; Mutai K; Dowdy D; Beyrer C
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25499. PubMed ID: 32562353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incremental cost of implementing the world health organization Package of essential non-communicable (PEN) diseases interventions in Iran.
    Azmin M; Mohebi F; Yoosefi M; Ahmadi N; Shirazi S; Modirian M; Farzadfar F
    PLOS Glob Public Health; 2023; 3(2):e0000449. PubMed ID: 36962715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; Keskinkiliç B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.
    Kapur A; Hod M
    Int J Gynaecol Obstet; 2020 Aug; 150(2):151-158. PubMed ID: 32401348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macroeconomic burden of noncommunicable diseases associated with air pollution in China.
    Chen S; Bloom DE
    PLoS One; 2019; 14(4):e0215663. PubMed ID: 30998763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of national healthcare systems in the prevention and treatment of non-communicable diseases in sub-Saharan Africa.
    Arhin K; Asante-Darko D
    PLoS One; 2023; 18(11):e0294653. PubMed ID: 37972071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges facing programs for the prevention and control of non-communicable diseases in Iran: a qualitative study of senior managers' viewpoints.
    Partovi Y; Farahbakhsh M; Tabrizi JS; Gholipour K; Koosha A; Sharbafi J; Wilson A
    BMC Health Serv Res; 2022 Nov; 22(1):1354. PubMed ID: 36380327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy analysis of nutrition stewardship for prevention and control of Non-communicable diseases in Iran.
    Amerzadeh M; Takian A; Pouraram H; Sari AA; Ostovar A
    BMC Health Serv Res; 2023 Jan; 23(1):79. PubMed ID: 36694184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.
    Hutchinson B; Small R; Acquah K; Sandoval R; Nugent R; Davidson T; Belausteguigoitia DI; Banatvala N; Webb D; Tarlton D; Kulikov A; Prieto E; Santi K
    PLoS One; 2019; 14(10):e0223412. PubMed ID: 31584979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.